Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

BusinessWeek June 21, 2004 Catherine Arnst	Guard Your Bones Osteoporosis is one of the biggest health risks facing older women. What can be done to help prevent this disease?
Nutra Solutions July 23, 2007 Ginny Banks	A New Look at Bone Health Although vitamin D and calcium are the mainstay ingredients for osteoporosis prevention, studies show that vitamin K2, phosphorous, magnesium, prebiotics and soy can also play a role.
American Family Physician October 1, 2004 Thomas M. Zizic	Pharmacologic Prevention of Osteoporotic Fractures Of the drugs that have been approved for the prevention or treatment of osteoporosis, the bisphosphonates (risedronate and alendronate) are most effective in reducing the risk of vertebral and nonvertebral fractures.
American Family Physician April 1, 2003 Campion & Maricic	Osteoporosis in Men Osteoporosis in men is now recognized as an increasingly important public health issue. Increased awareness by physicians of risk factors for male osteoporosis -- and early diagnosis and treatment -- are needed to decrease the morbidity and mortality resulting from osteoporotic fractures.
Nurse Practitioner June 2009 Ivy M. Alexander	Pharmacotherapeutic management of osteoporosis and osteopenia The estimated number of individuals with osteoporosis and osteopenia, the precursor to osteoporosis, continues to increase.
American Journal of Nursing August 2011 Karen Roush	Prevention and Treatment of Osteoporosis in Postmenopausal Women: A Review This article provides an overview of osteoporosis, describes current recommendations for its prevention and treatment, and discusses nursing implications.
American Family Physician March 1, 2004	Osteoporosis The definition, signs, and who's at risk of getting osteoporosis.
American Family Physician March 15, 2001 Jeannette E. South-Paul	Osteoporosis: Part II. Nonpharmacologic and Pharmacologic Treatment Family physicians will frequently encounter patients with osteoporosis, a condition that is often asymptomatic until a fracture occurs...
American Family Physician March 1, 2001	What You Should Know About Osteoporosis What is osteoporosis?... Who gets osteoporosis?... What are the effects of osteoporosis?... How does my doctor know I have osteoporosis?... How is osteoporosis treated?... How is osteoporosis prevented?... etc.
Food Processing June 2013 Mark Anthony	Boning Up on Nutrition: Food Manufacturers Take a Closer Look at Dietary Calcium With a $4 billion bone and joint health market, functional ingredient manufacturers look to dietary calcium and Vitamin D's capabilities to help restore cracks in bone health.
Seasoned Cooking July 2005 Michael Fick	Dem Bones Unless we patients, our doctors, and the whole medical profession change our acts, our aging population, lazier lifestyles, and junk food diets will lead to half of Americans over the age of 50 having osteoporosis or being at high risk for it.
The Motley Fool April 21, 2011 Luke Timmerman	Amgen Passes Key Trial With "Son of Dmab" for Osteoporosis The medical and scientific world will be chirping today about an interesting new finding Amgen has made for treating osteoporosis.
BusinessWeek June 21, 2004 Carol Marie Cropper	Osteoporosis: Men Suffer, Too Bone loss is a bigger threat than prostate cancer for men.
Food Processing June 2011 Dave Fusaro	How Can Food Processors Help Consumers' Aching and Aging Bones? Beyond vitamin D and phosphate, new ingredients help support calcium.
American Family Physician March 1, 2001 Jeannette E. South-Paul	Osteoporosis: Part I. Evaluation and Assessment Because osteoporosis is usually asymptomatic until a fracture occurs, family physicians must identify the appropriate timing and methods for screening those at risk...
Chemistry World January 26, 2015 Phillip Broadwith	Shire deepens rare disease focus with NPS buyout UK specialty pharmaceutical firm Shire has agreed to buy US biotech NPS Pharmaceuticals for $5.2 billion.
Science News November 12, 2005 Janet Raloff	Vitamin D Boosts Calcium Potency A new study shows that how much calcium a woman needs to keep bones strong depends largely on an individual's daily intake of vitamin D.
HHMI Bulletin May 2011 Dan Ferber	Revealing the Biological Complexity of Bones Bones are the body's framework and support, our strongest tissues. Unlike the scaffold of a building, however, bones are anything but inert. They pulse with life and their maintenance requires a surprisingly delicate balancing act.
Delicious Living April 2005 Anne Burnett	Kids need calcium and exercise Researchers suggest that because at least 90 percent of peak bone mass is accrued by the end of adolescence, it is important to optimize bone growth in younger years.
American Family Physician April 15, 2004 Bazaldua & Bruder	STEPS Drug Update Teriparatide (Forteo) for Osteoporosis
American Family Physician March 15, 2004	Use of Ultra-Low-Dose Estrogen to Prevent Bone Loss Estrogen therapy recently has been shown to increase the risk of breast cancer, heart disease, stroke, and deep venous thrombosis, but it also decreases the risk of hip fracture.
The Motley Fool February 9, 2011 Luke Timmerman	Amgen Pushes Ahead With "Son of Dmab" for Treating Bones Is there more to Amgen than "Dmab"?
Science News August 28, 2004	Bone Biology A new Web site provides information to physicians and others about bone physiology and osteoporosis.
BusinessWeek January 14, 2010 Rob Waters	Amgen: Strengthening Bones, Weakening Cancer? Regulators may soon approve an Amgen drug, denosumab, for osteoporosis, but the payoff could be in oncology.
Prepared Foods June 2, 2006 Kerry Hughes	Formulating for Women's Health The Women's Health Initiative has overturned what we knew about women's health in the past few years. This information has important implications for formulators who develop foods targeted toward women or their diets.
BusinessWeek August 13, 2009 Arlene Weintraub	Amgen's Bone-Loss Drug Faces Marketing Hurdles Amgen is likely to receive FDA approval for denosumab, its new biologic bone-loss drug, but it may be a hard sell against cheaper generics.
American Family Physician April 1, 2002 Richard Brunader	Radiologic Bone Assessment in the Evaluation of Osteoporosis Because osteoporosis affects a large number of patients with potentially significant morbidity and mortality, it is important to identify patients at risk so that physicians can effectively intervene...
The Motley Fool September 20, 2007 Billy Fisher	More Options for Healthy Bones? Novartis and Wyeth might be able to offer alternative treatments for osteoporosis, but the companies have a tough road ahead in this market.
The Motley Fool February 26, 2010 Brian Orelli	Boning Up on Pfizer's Drug Fablyn looks OK on paper, but that isn't going to cut it in the crowded osteoporosis market.
Food Processing April 2006 Mark Anthony	Calcium and Vitamin D Duet It's well known that calcium is needed for bone health, but vitamin D is often taken for granted.
Food Processing June 2006 Shelke & Messina	Menopause's Nutrition Equation Today, more than a third of the contemporary woman's life is in menopausal and post-menopausal phases. Not surprisingly, more functional foods are addressing major needs of women.
Outside November 2005 Roy Wallack	The Shatter-Proof Skeleton Low-impact sports may lead to bone-density loss. Load-bearing exercises and calcium can prevent osteoporosis.
Chemistry World May 8, 2007 Lionel Milgrom	Yearly Anti-Osteoporosis Jab Goes Straight to the Bone One injection of a new anti-osteoporosis drug a year can stop osteoporotic bone fractures in post-menopausal women, report researchers. The drug is already marketed by Novartis as Zometa (zoledronic acid) for use in several other disorders.
The Motley Fool October 7, 2004 Charly Travers	Amgen's Next Blockbuster An osteoporosis drug could give the company its next big winner. With a P/E back in the mid 20s, the company is valued such that Amgen shareholders should be rewarded in the future if products are successful.
The Motley Fool November 19, 2010 Brian Orelli	One Drug, Two Names, Two Wildly Different Prospects Amgen double speaks for increased sales.
The Motley Fool January 28, 2008 Brian Lawler	A Wing and a Prayer for Amgen Amgen announces data from its top pipeline drug candidate. Investors, take note.
Pharmaceutical Executive October 1, 2008 Joanna Breitstein	The D-Mab Men Amgen's salvation just may be denosumab. We sit down to talk with the head scientists driving the drug for the multi-billion dollar osteoporosis market
The Motley Fool July 8, 2009 Brian Orelli	Amgen Closes In on a Home Run Amgen already had a ball flying high above the outfield in its osteoporosis treatment, denosumab, but yesterday's clinical trial results were the wind that could push it out of the park.
American Family Physician July 1, 2002 Vincent Morelli	Alternative Therapies for Traditional Disease States: Menopause For most women, menopause is a normal phase of life that does not require medical intervention. However, some perimenopausal women seek treatment for vasomotor symptoms, while postmenopausal women may need treatment that can reduce their risk of cardiovascular disease and osteoporosis.
Science News October 28, 2006 Janet Raloff	Cola May Weaken Women's Bones New research indicates that, in postmenopausal women, regular consumption of cola-flavored soft drinks may weaken bones.
Science News August 28, 2004 Janet Raloff	We're Very Supplemented Increasingly, men and women are reaching for pills--vitamins, minerals, and other commercial supplements--to insure against the possibility they're not eating a healthy diet. While that's good news, there can also be a down side.
The Motley Fool March 11, 2010 Brian Orelli	FDA Still Has a Bone to Pick With These Drugmakers Osteoporosis drugs remain under the microscope.
Science News September 11, 2004 Janet Raloff	Should Foods Be Fortified Even More? A team of nutritionists is recommending that the federal government mandate the fortification of cereal-grain products, with calcium and vitamin D. Together, the two nutrients would add an estimated $.06 to $.10 to the cost of food per person per year.
Science News October 16, 2004 Janet Raloff	Is Vitamin D Fattening? One of the newest identified functions of the hormonal form of vitamin D, known as 1,25-D, is its role in determining how the body manages energy. The hormone actually promotes weight gain by sending calories into storage.
Science News May 7, 2005 Janet Raloff	Bread and Chocolate, No Longer D-Minimus One midwestern company is responding to growing concerns about chronic, widespread vitamin D deficiency by pioneering the robust fortification of new foods.
Nutra Solutions April 1, 2006 Kerry Hughes	Bone Up and Take Heart Lurking among our dietary leafy greens is a key fat-soluble vitamin that allows humans to form bones and clot blood - vitamin K.
The Motley Fool September 2, 2009 Robert Steyer	Pharma's Next Home Run Drug Could Be 4 Singles Instead With mixed success in the women's health field, drugmakers try to turn a single compound into a treatment for several diseases and conditions.
Prepared Foods February 1, 2005 Andrew G. Ebert	Ingredient Challenges Phosphorus: The Forgotten, Essential Ingredient When using phosphates as functional food ingredients, food manufacturers also have the opportunity to enhance the nutritional value of their products through the addition of phosphorus. But the importance of appropriate usage levels should not be overlooked.
The Motley Fool October 22, 2009 Brian Orelli	Good Luck in 2010, Amgen Just when it looked like Amgen was turning things around the Food and Drug Administration threw a wrench in the biotech's plans for its osteoporosis drug Prolia.
American Family Physician May 1, 2003 Carroll & Schade	A Practical Approach to Hypercalcemia Hypercalcemia is a disorder commonly encountered by primary care physicians. The diagnosis often is made incidentally in asymptomatic patients. Clinical manifestations affect the neuromuscular, gastrointestinal, renal, skeletal, and cardiovascular systems.